View Full Text | Abstract |
Article as PDF | Print this Article |
Pubmed | PMC |
PubReader | Export to Citation |
Email Alerts | Open Access |
Exp Neurobiol 2015; 24(2): 173-175
Published online June 30, 2015
https://doi.org/10.5607/en.2015.24.2.173
© The Korean Society for Brain and Neural Sciences
Perandones C1*, Pellene LA2, Giugni JC2, Calvo DS2, RainaGB2, Cuevas SM2, Mata IF3, Zabetian CP3, Caputo M4,Corach D4, Micheli FE2 and Radrizzani M5
1Parkinson's Disease and Movement Disorders Program, Hospital de Clínicas, University of Buenos Aires, Ciudad Autónoma de Buenos Aires,C1120AAR, Argentina, National Agency of Laboratories and Health Institutes of Argentina, (ANLIS) Dr. Carlos G. Malbrán, Ciudad Autónoma de Buenos Aires, 1281, Argentina, 2Parkinson's Disease and Movement Disorders Program, Hospital de Clínicas, University of Buenos Aires, Ciudad Autónoma de Buenos Aires,C1120AAR, Argentina, 3University of Washington and VA Puget Sound Health Care System, Seattle,WA 98108-1597, United States, 4Servicio de Huellas Digitales Genéticas, School of Pharmacy and Biochemistry, University of Buenos Aires, Ciudad Autónoma de Buenos Aires, 1113, Argentina, 5Laboratory of Neuro and Molecular Cytogenetic (CONICET), School of Sciences and Technology, CESyMA, National University of San Martin, Buenos Aires, 1650, Argentina
Correspondence to: *To whom correspondence should be addressed.
TEL: 0054-911 4564 5558, FAX: 0054-11-4580-7296, extension 107
e-mail: claudia.perandones@gmail.com